Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 2, 1996, Pages 547-554

  Tonacchera, M ^a,e   Van Sande, J ^a   Cetani, F ^a   Swillens, S ^a   Schvartz, C ^b   Winiszewski, P ^c   Portmann, L ^d   Dumont, J E ^a   Vassart, G ^a   Parma, J ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b INSTITUT JEAN GODINOT   (France)

^c Serv d'Endocrinol Diabet M   (France)

^d Division d'Endocrinologie   (Switzerland)

^e FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; DNA; INOSITOL PHOSPHATE; IODINE 125; THYROTROPIN RECEPTOR;

ANIMAL CELL; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BINDING AFFINITY; CASE REPORT; GENE MUTATION; HUMAN; HUMAN CELL; HYPERTHYROIDISM; NONHUMAN; PEDIGREE ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 9044240477     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.2.547     Document Type: Article

References (30)

1. McKenzie JM, Zakarija M. 1995 Hyperthyroidism. In: De Groot LJ, ed. Endocrinology. Philadelphia: Saunders; vol 1:343-364.
2. Laurent E, Van Sande J, Ludgate M, et al. 1991 Unlike thyrotropin, thyroid-stimulating antibodies do not activate phospholipase C in human thyroid slices. J Clin Invest. 87:1-9.
3. Vassart G, Dumont JE. 1992 The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr Rev. 13:596-611.
4. Nagayama Y, Rapoport B. 1992 The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning. Mol Endocrinol. 6:145-156.
5. Laurent E, Mockel J, Van Sande J, Graff I, Dumont JE. 1987 Dual activation by thyrotropin of the phospholipase C and cyclic AMP cascades in human thyroid. Mol Cell Endocrinol. 52:273-278.
6. Van Sande J, Raspe E, Perret J, et al. 1990 Thyrotropin activates both the cAMP and the PIP2 cascades in CHO-K1 cells expressing the human cDNA of thyrotropin receptor. Mol Cell Endocrinol. 74:R1-R6.
7. 11. J Biol Chem. 269:13733-13735.
8. Robinson PR, Cohen GB, Zhukovsky EA, Oprian DD. 1992 Constitutively active mutants of rhodopsin. Neuron. 9:719-725.
9. Shenker A, Laue L, Kosugi S, Merendino JJ, Minegishi T, Cutler GB. 1993 A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature. 365:652-654.
10. ++-sensing receptor gene mutation. Nature Genet. 8:303-307.
11. Schipani E, Kruse K, Juppner H. 1995 A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science. 268: 98-100.
12. Parma J, Duprez L, Van Sande J, et al. 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 365:649-651.
13. Porcellini A, Ciullo I, Laviola L, Amabile A, Fenzi G, Awedimento V. 1994 Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab. 79:657-661.
14. Paschke R, Tonacchera M, Van Sande J, Parma J, Vassart G. 1994 Identification and functional characterization of two new somatic mutations causing constitutive activation of the TSH receptor in hyperfunctioning autonomous adenomas of the thyroid. J Clin Endocrinol Metab. 79:1785-1789.
15. ++ cascades. Mol Endocrinol. 9:725-733.
16. Duprez L, Parma J, Van Sande J, et al. 1994 Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nature Genet. 7:396-401.
17. Kopp P, Van Sande J, Parma J, et al. 1995 Congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med. 332:150-154.
18. Thomas JL, Leclere J, Hartemann P, et al. 1982 Familial hyperthyroidism without evidence of autoimmunity. Acta Endocrinol (Copenh). 100:512-518.
19. Horton GL, Scazziga BR. 1987 Hereditary hyperthyroidism with diffuse non autoimmune hyperactivity due to autonomy of function and growth [Abstract]. Ann Endocrinol (Paris). 48:92.
20. Berridge MJ. 1983 Rapid accumulation of inositol triphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol. Biochem J. 212:849-858.
21. Rapoport B, Seto P. 1985 Bovine thyrotropin has a specific bioactivity 5- to 10-fold that of previous estimates for highly purified hormone. Endocrinology. 116:1379-1382.
22. Swillens S. 1995 Interpretation of binding curves obtained with high receptor concentrations: practical aid for computer analysis. Mol Pharmacol. 47:1197-1203.
23. Van Sande J, Swillens S, Gerard C, et al. 1995 In Chinese hamster ovary K1 cells dog and human thyrotropin receptors activate both the cAMP and the phosphatidylinositol 4,5-biphosphate cascades in the presence of thyrotropin and the cAMP cascade in its absence. Eur J Biochem. 229:338-343.
24. Dumont JE, Lamy F, Roger P, Maenhaut C. 1992 Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev. 72:667-697.
25. Roger P, Taton M, Van Sande J, Dumont JE. 1988 Mitogenic effects of thyrotropin and cyclic AMP in differentiated human thyroid cells in vitro. J Clin Endocrinol Metab. 66:1158-1165.
26. Lefkowitz RJ, Cotecchia S, Samama P, Costa T. 1994 Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci. 14:303-307.
27. Samama P, Cotecchia S, Costa T, Lefkowitz RJ. 1993 A mutation-induced activated state of the beta-2 adrenergic receptor. Extending the ternary complex model. J Biol Chem. 268:4625-4636.
28. Van Sande J, Parma J, Tonacchera M, Dumont J, Vassart G. 1995 Somatic and germline mutations of the TSH receptor gene in thyroid diseases. J Clin Endocrinol Metab. 80:2577-2585.
29. Rao VR, Cohen GB, Oprian DD. 1994 Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness. Nature. 367:639-642.
30. Baldwin JM. 1993 The probable arrangement of the helices in G protein-coupled receptors. EMBO J. 12:1693-1703.